Baldwin Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,775
| Closed | -$201 | – | 249 |
|
|
2021
Q4 | $201 | Sell |
2,775
-3,650
| -57% | -$251K | 0.03% | 251 |
|
|
2021
Q3 | $449K | Sell |
6,425
-150
| -2% | -$10.5K | 0.08% | 165 |
|
|
2021
Q2 | $453K | Sell |
6,575
-283
| -4% | -$18.9K | 0.08% | 167 |
|
|
2021
Q1 | $443K | Sell |
6,858
-1,150
| -14% | -$74.2K | 0.08% | 162 |
|
|
2020
Q4 | $467K | Sell |
8,008
-1,117
| -12% | -$67.4K | 0.09% | 150 |
|
|
2020
Q3 | $577K | Buy |
9,125
+1,775
| +24% | +$123K | 0.14% | 111 |
|
|
2020
Q2 | $566K | Buy |
7,350
+400
| +6% | +$30.7K | 0.18% | 86 |
|
|
2020
Q1 | $520K | Sell |
6,950
-50
| -0.7% | -$3.46K | 0.18% | 78 |
|
|
2019
Q4 | $455K | Sell |
7,000
-100
| -1% | -$6.51K | 0.12% | 119 |
|
|
2019
Q3 | $450K | Buy |
7,100
+500
| +8% | +$32.7K | 0.13% | 116 |
|
|
2019
Q2 | $446K | Buy |
6,600
+100
| +2% | +$6.58K | 0.13% | 113 |
|
|
2019
Q1 | $423K | Sell |
6,500
-900
| -12% | -$59.8K | 0.13% | 113 |
|
|
2018
Q4 | $463K | Sell |
7,400
-600
| -8% | -$41.9K | 0.15% | 99 |
|
|
2018
Q3 | $618K | Sell |
8,000
-150
| -2% | -$11.3K | 0.18% | 88 |
|
|
2018
Q2 | $577K | Sell |
8,150
-500
| -6% | -$35.3K | 0.18% | 91 |
|
|
2018
Q1 | $652K | Sell |
8,650
-270
| -3% | -$21.5K | 0.23% | 61 |
|
|
2017
Q4 | $639K | Sell |
8,920
-1,440
| -14% | -$109K | 0.23% | 62 |
|
|
2017
Q3 | $839K | Hold |
10,360
| – | – | 0.32% | 50 |
|
|
2017
Q2 | $733K | Sell |
10,360
-710
| -6% | -$47.2K | 0.29% | 55 |
|
|
2017
Q1 | $752K | Sell |
11,070
-200
| -2% | -$14.1K | 0.29% | 53 |
|
|
2016
Q4 | $807K | Hold |
11,270
| – | – | 0.32% | 49 |
|
|
2016
Q3 | $892K | Buy |
11,270
+1,025
| +10% | +$83.3K | 0.38% | 43 |
|
|
2016
Q2 | $855K | Sell |
10,245
-210
| -2% | -$18.6K | 0.37% | 42 |
|
|
2016
Q1 | $960K | Buy |
10,455
+4,873
| +87% | +$439K | 0.41% | 38 |
|
|
2015
Q4 | $565K | Buy |
5,582
+127
| +2% | +$13.2K | 0.25% | 63 |
|
|
2015
Q3 | $536K | Buy |
5,455
+200
| +4% | +$22.2K | 0.24% | 68 |
|
|
2015
Q2 | $615K | Sell |
5,255
-215
| -4% | -$23.5K | 0.25% | 64 |
|
|
2015
Q1 | $537K | Buy |
5,470
+250
| +5% | +$25.4K | 0.21% | 72 |
|
|
2014
Q4 | $492K | Hold |
5,220
| – | – | 0.19% | 79 |
|
|
2014
Q3 | $556K | Hold |
5,220
| – | – | 0.23% | 71 |
|
|
2014
Q2 | $433K | Buy |
5,220
+620
| +13% | +$48.3K | 0.19% | 87 |
|
|
2014
Q1 | $326K | Hold |
4,600
| – | – | 0.14% | 102 |
|
|
2013
Q4 | $345K | Hold |
4,600
| – | – | 0.16% | 96 |
|
|
2013
Q3 | $289K | Hold |
4,600
| – | – | 0.14% | 106 |
|
|
2013
Q2 | $236K | Buy |
+4,600
| New | +$240K | 0.12% | 110 |
|
Other funds holding GILD
Baldwin Investment Management's GILD Position: Q1 2022 in Review
Baldwin Investment Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 2,775 shares — an estimated $201 sold.
Baldwin Investment Management first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $960K in Q1 2016. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Baldwin Investment Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Baldwin Investment Management sold 2,775 Gilead Sciences shares in Q1 2022, an estimated $201.
- Baldwin Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- Baldwin Investment Management's Gilead Sciences position peaked at $960K in Q1 2016.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Baldwin Investment Management's 13F filing for Q1 2022, filed 16 May 2022.